Last reviewed · How we verify
Ethinone — Competitive Intelligence Brief
phase 3
ethisterone
Sex hormone-binding globulin, Glucocorticoid receptor, Androgen receptor
Other
Small molecule
Live · refreshed every 30 min
Target snapshot
Ethinone (ETHISTERONE). Ethinone works by binding to sex hormone-binding globulin, affecting the levels of sex hormones in the body.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ethinone TARGET | ETHISTERONE | phase 3 | ethisterone | Sex hormone-binding globulin, Glucocorticoid receptor, Androgen receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (ethisterone class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ethinone CI watch — RSS
- Ethinone CI watch — Atom
- Ethinone CI watch — JSON
- Ethinone alone — RSS
- Whole ethisterone class — RSS
Cite this brief
Drug Landscape (2026). Ethinone — Competitive Intelligence Brief. https://druglandscape.com/ci/ethisterone. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing